These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36967456)

  • 1. National trends in the prescribing of Ninjin'yoeito, a Kampo medicine, for older adults from 2015 to 2020 in Japan.
    Sasaki Y; Hamada S; Arai I; Sakata N
    Geriatr Gerontol Int; 2023 May; 23(5):396-398. PubMed ID: 36967456
    [No Abstract]   [Full Text] [Related]  

  • 2. Disuse muscle atrophy-improving effect of ninjin'yoeito in a mouse model.
    Takemoto R; Sejima T; Han LK; Michihara S; Takahashi R
    Neuropeptides; 2021 Dec; 90():102199. PubMed ID: 34610544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit.
    Aomatsu N; Shigemitsu K; Nakagawa H; Morooka T; Ishikawa J; Yamashita T; Tsuruoka A; Fuke A; Motoyama K; Kitagawa D; Ikeda K; Maeda K; Shirano M; Rinka H
    Neuropeptides; 2021 Dec; 90():102201. PubMed ID: 34753072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ninjin'yoeito, a traditional Japanese medicine, increases dopamine content in PC12 cells.
    Miyazaki S; Omiya Y; Mizoguchi K
    Biosci Biotechnol Biochem; 2021 Oct; 85(11):2274-2280. PubMed ID: 34529031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the usefulness of Ninjin'yoeito Kampo medicine in combination with rehabilitation therapy in patients with frailty complicated by intractable dizziness.
    Arai M
    Neuropeptides; 2021 Dec; 90():102189. PubMed ID: 34481223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Effects of Ninjin'yoeito on Physical Frailty in Mice.
    Otsuka S; Fukumaru K; Tani A; Takada S; Kikuchi K; Norimatsu K; Matsuzaki R; Matsuoka T; Sakakima H; Omiya Y; Mizuno K; Matsubara Y; Maruyama I
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty.
    Uto NS; Amitani H; Atobe Y; Sameshima Y; Sakaki M; Rokot N; Ataka K; Amitani M; Inui A
    Front Nutr; 2018; 5():126. PubMed ID: 30619872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicological considerations of Kampo medicines in clinical use.
    Ikegami F; Fujii Y; Satoh T
    Toxicology; 2004 May; 198(1-3):221-8. PubMed ID: 15138045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple stage IV colorectal cancers in a patient who received multidisciplinary treatment, including chemotherapy and Japanese Kampo medicine: A case report.
    Aomatsu N; Maeda K; Uchima Y; Matsutani S; Tsujio G; Miyamoto H; Okada T; Kurihara S; Nishii T; Tachimori A; Ikeda K; Takeuchi K
    Neuropeptides; 2021 Aug; 88():102160. PubMed ID: 34004454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ninjin'yoeito, a traditional Japanese Kampo medicine, suppresses the onset of anhedonia induced by dysfunction in the striatal dopamine receptor type 2-expressing medium spiny neurons.
    Oizumi H; Imai R; Suzuki T; Omiya Y; Tanaka KF; Mimura M; Mizoguchi K
    Neuroreport; 2021 Jul; 32(10):869-874. PubMed ID: 34029288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ninjin'yoeito reduces fatigue-like conditions by alleviating inflammation of the brain and skeletal muscles in aging mice.
    Otsuka S; Matsuzaki R; Kakimoto S; Tachibe Y; Kawatani T; Takada S; Tani A; Nakanishi K; Matsuoka T; Kato Y; Inadome M; Nojima N; Sakakima H; Mizuno K; Matsubara Y; Maruyama I
    PLoS One; 2024; 19(5):e0303833. PubMed ID: 38768175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicological aspects of Kampo medicines in clinical use.
    Ikegami F; Fujii Y; Ishihara K; Satoh T
    Chem Biol Interact; 2003 Jun; 145(3):235-50. PubMed ID: 12732452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reviewing Kampo medicine (Traditional Japanese Herbal Medicine) for otology/neurotology diseases.
    Okayasu T; Mitani K; Kitahara T
    Auris Nasus Larynx; 2024 Feb; 51(1):25-30. PubMed ID: 37137794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty.
    Hirai K; Homma T; Matsunaga T; Akimoto K; Yamamoto S; Suganuma H; Kashima A; Sato H; Ebato T; Miyata Y; Ohta S; Inoue H; Kusumoto S; Suzuki S; Tanaka A; Sagara H
    J Altern Complement Med; 2020 Aug; 26(8):750-757. PubMed ID: 32551796
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID.
    Tokumasu K; Ueda K; Honda H; Sunada N; Sakurada Y; Matsuda Y; Nakano Y; Hasegawa T; Otsuka Y; Obika M; Hagiya H; Kataoka H; Otsuka F
    Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term administration of ninjin'yoeito to treat frailty in older adults: A case series.
    Sakisaka N
    Neuropeptides; 2022 Jun; 93():102244. PubMed ID: 35381491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicine and food with particular reference to chinpi, dried citrus peel, and a component of Ninjin'yoeito.
    Sakaki M; Harai K; Takahashi R; Amitani M; Amitani H; Takimoto Y; Inui A
    Neuropeptides; 2021 Oct; 89():102166. PubMed ID: 34174540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ninjin'yoeito, a traditional Japanese medicine, attenuates age-related deficits of muscle performance, self-care motivation, and body temperature in C57BL/6 mice.
    Matsubara Y; Miyama Y; Imai R; Oizumi H; Miyazaki S; Haneda E; Mizuno K; Omiya Y; Ikeda Y; Mizoguchi K
    Biosci Biotechnol Biochem; 2022 Jun; 86(7):895-901. PubMed ID: 35396846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice.
    Matsumoto T; Takiyama M; Sakamoto T; Kaifuchi N; Watanabe J; Takahashi Y; Setou M
    J Ethnopharmacol; 2021 Oct; 279():114332. PubMed ID: 34129897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.